Skip to main content
logo
Akums Drugs and Pharmaceuticals Limited (BOM:544222)
India flag India · Delayed Price · Currency is INR
603.70
+2.25 (0.37%)
At close: Jun 19, 2026

BOM:544222 Revenue

In the fiscal year ending March 31, 2026, Akums Drugs and Pharmaceuticals had annual revenue of 43.59B INR with 5.77% growth. Akums Drugs and Pharmaceuticals had revenue of 11.58B in the quarter ending March 31, 2026, with 9.39% growth.

Revenue
43.59B
Revenue Growth
+5.77%
P/S Ratio
2.17
Revenue / Employee
5.78M
Employees
7,536
Market Cap
94.50B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202643.59B2.38B5.77%
Mar 31, 202541.21B-605.31M-1.45%
Mar 31, 202441.82B5.24B14.34%
Mar 31, 202336.57B-180.32M-0.49%
Mar 31, 202236.75B9.49B34.81%
Mar 31, 2021 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Jubilant Pharmova82.80B
Granules India53.66B
Viyash Scientific34.20B
AstraZeneca Pharma India22.76B
Caplin Point Laboratories21.87B
FDC Limited21.71B
Sanofi India17.74B
Rubicon Research17.54B
Revenue Rankings

Akums Drugs and Pharmaceuticals News

More News